FDA Grants Accelerated Approval to Otarmeni Gene Therapy for OTOF-Related Hearing Loss

Audiologists should be aware that Otarmeni is now FDA-approved for OTOF-related hearing loss and begin familiarizing themselves with candidate identification (genetic testing referral pathways) and post-treatment audiological monitoring protocols, though prescribing authority...